[CLDX] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
03-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 4.66%
YoY- -31.27%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 1,874 1,790 1,477 620 3,647 2,434 37,721 -39.34%
PBT -32,307 -32,684 -31,821 -22,062 -16,807 -12,294 23,046 -
Tax -5,090 836 -229 -137 -94 268 1,449 -
NP -32,307 -32,684 -31,821 -22,062 -16,807 -12,732 22,661 -
Tax Rate - - - - - - -6.29% -
Total Cost 34,181 34,474 33,298 22,682 20,454 15,166 15,060 14.62%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -1,723.96 -1,825.92 -2,154.43 -3,558.39 -460.84 -523.09 60.08 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -4.49 -4.97 -5.33 -3.71 -4.03 -3.81 10.61 -
EPS Diluted -4.49 -4.97 -5.33 -3.71 -4.03 -3.81 10.61 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.